Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, Altieri MM, Bansal N, Bello NA, Bress AP, Carter J, Cohen JB, Collins KJ, Commodore-Mensah Y, Davis LL, Egan B, Khan SS, Lloyd-Jones DM, Melnyk BM, . . . Williamson JD (2025) 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice

Wang Y, Lee JS, Pollack LM, Kumar A, Honeycutt S, Luo F. Health care expenditures and use associated with hypertension among U.S. adults. Am J Prev Med. 2024;67(6):820–31. https://doi.org/10.1016/j.amepre.2024.07.005.

Article  PubMed  PubMed Central  Google Scholar 

Aggarwal R, Chiu N, Wadhera RK, et al. Racial/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013 to 2018. Hypertension. 2021;78(6):1719–26. https://doi.org/10.1161/HYPERTENSIONAHA.121.17570.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin SS, et al. 2025 Heart Disease and Stroke Statistics: A report of US and global data from the American heart association. Circulation. 2025;151(8):e41–660.

Article  PubMed  PubMed Central  Google Scholar 

Gao Y, Haddy N, Ferdinand KC. Women and hypertension: beyond the 2017 guideline for prevention, detection, evaluation, and management of high blood pressure in adults. Am J Hypertens. 2023;36(5):389–97. https://doi.org/10.1093/ajh/hpad002.

Article  Google Scholar 

Weng X, Woodruff RC, Park S, Thompson-Paul AM, He S, Hayes D, et al. Hypertension prevalence and control among U.S. women of reproductive age. Am J Prev Med. 2024;66(3):492–502. https://doi.org/10.1016/j.amepre.2023.10.016.

Article  PubMed  Google Scholar 

Kalenga CZ, Metcalfe A, Robert M, Nerenberg KA, MacRae JM, Ahmed SB. Association between the route of administration and formulation of estrogen therapy and hypertension risk in postmenopausal women: a prospective population‑based study. Hypertension. 2023;80(7):1463–73. https://doi.org/10.1161/HYPERTENSIONAHA.122.19938.

Article  CAS  PubMed  Google Scholar 

United Nations: Department of Economic and Social Affairs. World Family Planning 2022: Meeting the changing needs for family planning: Contraceptive use by age and method, contraceptive use by age and method. (United Nations, ed.). United Nations; 2023.

Cooper DB, Patel P, Mahdy H. Oral contraceptive pills. In: StatPearls. StatPearls Publishing; 2022.

Practice bulletin no. 110: Noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115(1):206–18.

Article  Google Scholar 

Cameron NA, Blyler CA, Bello NA. Oral contraceptive pills and hypertension: a review of current evidence and recommendations. Hypertension. 2023;0(80):924–35.

Article  CAS  Google Scholar 

Chasan-Taber L, Willett WC, Manson JE, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation. 1996;94(3):483–9.

Article  CAS  PubMed  Google Scholar 

Dong W, Colhoun HM, Poulter NR. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994. J Hypertens. 1997;15(10):1063–8.

Article  CAS  PubMed  Google Scholar 

Du Y, Melchert HU, Schäfer-Korting M. Use of oral contraceptives in Germany: prevalence, determinants and use-associated health correlates. Results of National Health Surveys from 1984 to 1999. Eur J Obstet Gynecol Reprod Biol. 2007;134(1):57–66.

Article  PubMed  Google Scholar 

Park H, Kim K. Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean women. BMC Womens Health. 2013;13:39.

Article  PubMed  PubMed Central  Google Scholar 

Wei W, Li Y, Chen F, et al. Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women. J Hum Hypertens. 2011;25(6):364–71.

Article  CAS  PubMed  Google Scholar 

Wang C, Li Y, Bai J, et al. General and central obesity, combined oral contraceptive use and hypertension in Chinese women. Am J Hypertens. 2011;24(12):1324–30.

Article  CAS  PubMed  Google Scholar 

White K, Potter JE, Hopkins K, Amastae J, Grossman D. Hypertension among oral contraceptive users in El Paso, Texas. J Health Care Poor Underserved. 2013;24(4):1511–21.

Article  PubMed  PubMed Central  Google Scholar 

Khader YS, Rice J, John L, Abueita O. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception. 2003;68(1):11–7.

Article  CAS  PubMed  Google Scholar 

Weir RJ, Briggs E, Mack A, Naismith L, Taylor L, Wilson E. Blood pressure in women taking oral contraceptives. BMJ. 1974;1(5907):533–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harvey RE, Hart EC, Charkoudian N, et al. Oral contraceptive use, muscle sympathetic nerve activity, and systemic hemodynamics in young women. Hypertension. 2015;66(3):590–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Graugaard-Jensen C, Hvistendahl GM, Frøkiær J, Bie P, Djurhuus JC. Oral contraceptives and renal water handling: a diurnal study in young women. Physiol Rep. 2017. https://doi.org/10.14814/phy2.13547.

Article  PubMed  PubMed Central  Google Scholar 

Glisic M, Shahzad S, Tsoli S, et al. Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis. Eur J Prev Cardiol. 2018;25(10):1042–52.

Article  PubMed  PubMed Central  Google Scholar 

de Souza IS, Laporta GZ, Zangirolami-Raimundo J, et al. Association between the use of oral contraceptives and the occurrence of systemic hypertension: A systematic review with statistical comparison between randomized clinical trial interventions. Eur J Obstet Gynecol Reprod Biol X. 2024;22(100307):100307.

PubMed  PubMed Central  Google Scholar 

Archer DF, Ahrendt HJ, Drouin D. Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability. Contraception. 2015;92(5):439–44.

Article  CAS  PubMed  Google Scholar 

Kimble T, Burke AE, Barnhart KT, Archer DF, Colli E, Westhoff CL. A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen. Contracept X. 2020;2:100020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC. Effect of oral contraceptives containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome. Contraception. 2010;82(2):139–46.

Article  CAS  PubMed  Google Scholar 

Yildizhan R, Yildizhan B, Adali E, Yoruk P, Birol F, Suer N. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure. Arch Gynecol Obstet. 2009;280(2):255–61.

Article  CAS  PubMed  Google Scholar 

US Medical Eligibility Criteria (US MEC) for Contraceptive Use, 2016. May 18, 2022. Accessed October 17, 2022. https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html.

Over-the-Counter Access to Hormonal Contraception. Accessed October 27, 2022. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/over-the-counter-access-to-hormonal-contraception.

Centers for Disease Control and Prevention. Combined Hormonal Contraceptives. Contraception. November 19, 2024. https://www.cdc.gov/contraception/hcp/usspr/combined-hormonal-contraceptives.html. Accessed May 13, 2025.

American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Gynecology. ACOG practice bulletin no. 194: Polycystic ovary syndrome. Obstet Gynecol 2018;131(6):e157-e171.

Salari N, Nankali A, Ghanbari A, et al. Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet. 2024;310(3):1303–14.

Article  PubMed  Google Scholar 

Briceño Silva GD, Thomas Garcia KD, Ajamyan H, et al. Polycystic ovarian syndrome: Exploring hypertension and cardiometabolic implications. Cureus. 2024;16(10):e70958.

PubMed  PubMed Central  Google Scholar 

Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol. 2020;18(1):23.

Article  PubMed  PubMed Central  Google Scholar 

Joham AE, Kakoly NS, Teede HJ, Earnest A. Incidence and predictors of hypertension in a cohort of Australian women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2021;106(6):1585–93.